IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$8.88 USD
+0.05 (0.57%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $8.90 +0.02 (0.23%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/15/24 |
---|---|
Current Quarter | 0.03 |
EPS Last Quarter | -0.83 |
Last EPS Surprise | 1.19% |
ABR | 1.90 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.31 |
Next Year | -3.18 |
EPS (TTM) | -4.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 51.75M | 0.50M | 53.23M | 19.44M |
# of Estimates | 6 | 6 | 6 | 4 |
High Estimate | 62.00M | 0.75M | 63.50M | 39.75M |
Low Estimate | 0.75M | 0.25M | 3.00M | 3.00M |
Year ago Sales | 0.45M | 0.51M | 2.13M | 53.23M |
Year over Year Growth Est. | 11,400.00% | -1.37% | 2,399.15% | -63.49% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03 | -0.84 | -2.31 | -3.18 |
# of Estimates | 7 | 6 | 6 | 7 |
Most Recent Consensus | 0.21 | -0.83 | -2.31 | -3.66 |
High Estimate | 0.21 | -0.80 | -2.13 | -2.01 |
Low Estimate | -0.81 | -0.92 | -2.55 | -3.73 |
Year ago EPS | -1.43 | -1.04 | -4.71 | -2.31 |
Year over Year Growth Est. | 102.10% | 19.23% | 50.96% | -37.68% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.03 | -0.84 | -2.31 | -3.18 |
7 Days Ago | 0.03 | -0.84 | -2.31 | -3.18 |
30 Days Ago | 0.03 | -0.84 | -2.31 | -3.18 |
60 Days Ago | 0.03 | -0.84 | -2.31 | -3.18 |
90 Days Ago | -0.11 | -0.84 | -2.47 | -3.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | -0.84 | -2.31 | -3.18 |
Zacks Consensus Estimate | 0.03 | -0.84 | -2.31 | -3.18 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.83 | -1.01 | -1.04 | -1.43 | NA |
Estimate | -0.84 | -1.06 | -1.25 | -1.43 | NA |
Difference | 0.01 | 0.05 | 0.21 | 0.00 | 0.07 |
Surprise | 1.19% | 4.72% | 16.80% | 0.00% | 5.68% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more